Underdog Pharmaceuticals
Latest round
- Seed
Last raised
- Nov 2019
Total raised
- $4M
Investors
- 1
About Underdog Pharmaceuticals
Underdog Pharmaceuticals, Inc.Underdog Pharmaceuticals, Inc. specializes in creating drug therapies to combat age-related diseases. Founded in 2019 by Amelia Anderson, Matthew O'Connor, and Michael Kope, the company is headquartered in Mountain View, US.Underdog Pharmaceuticals, Inc. focuses on the development of innovative drug therapies aimed at treating age-related diseases, specifically targeting atherosclerosis, heart attacks, and strokes. The company’s core offerings utilize novel derivatives of a recognized safe compound that works by removing arterial plaque and clearing non-degradable cholesterol from artery wall cells.Underdog Pharmaceuticals, Inc. generates revenue through direct-to-consumer sales as well as partnerships with healthcare providers. The company employs a subscription model or direct sales strategy to offer their innovative therapies to healthcare entities.95 mn secured in November 2019, Underdog Pharmaceuticals, Inc. aims to advance its product development and expand its market reach. The company plans to introduce new products targeting cardiovascular health and aims to enter additional markets within the US and Europe by 2022.
Who invested in Underdog Pharmaceuticals
1 investor across 1 round
See all investors in Underdog Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 14, 2019
Amount
$4M
Investors
Questions about Underdog Pharmaceuticals
Who invested in Underdog Pharmaceuticals?
Underdog Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Underdog Pharmaceuticals raised?
Underdog Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Underdog Pharmaceuticals last raise money?
Underdog Pharmaceuticals's most recent round on record is a Seed, in Nov 2019.
What does Underdog Pharmaceuticals do?
Underdog Pharmaceuticals is a healthcare company.
Where is Underdog Pharmaceuticals headquartered?
Underdog Pharmaceuticals is headquartered in Mountain View, US.
Which VCs invest in companies like Underdog Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Underdog Pharmaceuticals's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Underdog Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.